journal cover

Central nervous system brucellosis: presentation, diagnosis and treatment

The Journal of Infection

Nov 20, 1998

Hayrettin AkdenizAli Pekcan Demiröz

PMID: 9661940

Download from

PubMed

Abstract

Although neurological symptoms in brucellosis are frequent, central nervous system (CNS) involvement is uncommon. Five patients with neurobrucellosis are presented. Three patients presented with meningoencephalitis, one with polyradiculoneuritis and one with myelitis and an eighth nerve...read more

Mentioned in this Paper

Doxycycline
Polyradiculoneuropathy
Neurologic Manifestations
Ceftriaxone
Bacteriocidal Agents
Ciprofloxacin
Entire Central Nervous System
Cerebrospinal Fluid
Streptomycin
Brucella Melitensis Infection
Paper Details
References
  • References4
  • Citations36
1
  • References4
  • Citations36
1234

Feeds With Similar Papers

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Demyelinating Disorders of the CNS

Demyelinating diseases result in damage to the myelin sheath that surrounds nerves in the brain and spinal cord and can result in neurological conditions such as multiple sclerosis. Here is the latest research on demyelinating disorders of the central nervous system.

Brucellosis (ASM)

Brucellosis is a bacterial infection caused by members of the genus brucella and remains one of the world's major zoonotic diseases. Discover the latest research on Brucellosis here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Brucellosis

Brucellosis is a bacterial infection caused by members of the genus brucella and remains one of the world's major zoonotic diseases. Discover the latest research on Brucellosis here.

Meningoencephalitis

Meningoencephalitis, also known as herpes meningoencephalitis, is a medical condition that simultaneously resembles both meningitis, which is an infection or inflammation of the meninges, and encephalitis, which is an infection or inflammation of the brain. Discover the latest research on meningoencephalitis here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

Neurobrucellosis: clinical and therapeutic features(opens in new tab)

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of AmericaOctober 1, 1992
D R McLeanM Y Khan
© 2020 Meta ULC. All rights reserved

Central nervous system brucellosis: presentation, diagnosis and treatment

The Journal of Infection

Nov 20, 1998

Hayrettin AkdenizAli Pekcan Demiröz

PMID: 9661940

DOI:

Abstract

Although neurological symptoms in brucellosis are frequent, central nervous system (CNS) involvement is uncommon. Five patients with neurobrucellosis are presented. Three patients presented with meningoencephalitis, one with polyradiculoneuritis and one with myelitis and an eighth nerve...read more

Mentioned in this Paper

Doxycycline
Polyradiculoneuropathy
Neurologic Manifestations
Ceftriaxone
Bacteriocidal Agents
Ciprofloxacin
Entire Central Nervous System
Cerebrospinal Fluid
Streptomycin
Brucella Melitensis Infection

Feeds With Similar Papers

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

Neurobrucellosis: clinical and therapeutic features(opens in new tab)

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of AmericaOctober 1, 1992
D R McLeanM Y Khan
Paper Details
References
  • References4
  • Citations36
1
  • References4
  • Citations36
1234

Download from

PubMed
/papers/central-nervous-system-brucellosis-presentation/9661940